Wall Street reaction to Berkshire Hathaway’s investment in Teva Pharmaceuticals
After Berkshire Hathaway (BRK) disclosed its investment of $358 million in Teva Pharmaceuticals (TEVA) on February 14, 2018, in a regulatory filing at the end of 4Q17, Wall Street analysts have had a lot to say about the investment. Teva Pharmaceuticals stock rose ~10.5% during the morning of February 15, 2018, before closing at a rise of ~7.7% on the day. The PowerShares International Dividend Achievers Portfolio (PID) rose ~1.3% on February 15, 2018. PID holds ~4.5% of its total holdings in Teva stock.
Berkshire Hathaway hasn’t provided its rationale for its investment in Teva stock. However, as per Citigroup (C) analyst Liav Abraham, the company’s investment in the troubled pharma giant has reaffirmed the views of the analysts who say Teva is on the right track to a successful turnaround. The company has put forward a strong restructuring plan focused on disciplined debt repayments, as shown in the diagram above.
Raymond James & Associates analyst Elliot Wilbur wrote in a note to clients, “Drug costs continue to escalate, Trump is all over prices, and Teva, along with the rest of the generics industry, is part of the solution.”
Lawrence Cunningham’s view on Berkshire’s investment in Teva
As per Lawrence Cunningham, author of Berkshire Beyond Buffett: The Enduring Value of Values, “It’s not classical Buffett, given the industry, so it’s likely the younger investors. But it’s classic Berkshire in being what some would call contrarian, though I would call it opportunistic. They invest capital in great businesses at a reasonable price, when others are negative enough to create those conditions.”
Analysts still advise caution
Teva stock has a “hold” rating from Sanford C. Bernstein analyst Ronnie Gal. As per the analyst, Berkshire’s investment in Teva “is a classic value situation. If you think they can make $3.5 billion to $4 billion a year in free cash flow to pay down debt, you buy the stock. If you think it’s $2.5 billion to $3 billion, you sell the stock. If interest rates go up, they’re in trouble because they have to refinance at higher rates. If rates stay low, they will be able to take down the debt.”
However, RBC Capital (RY) analyst Randall Stanicky expressed his apprehensions on the future prospects of Teva Pharmaceuticals despite Buffett’s investment in the company. As per Stanicky, “The $3 billion in cost cuts through 2019 are a necessary and effective address to near-term patent cliffs. But they do not solve Teva’s growth problem, and we still think the bull case is overestimating medium-term growth given the multiyear period of lack of business-development support.”
In fiscal 4Q17, PepsiCo (PEP) beat analysts’ earnings expectations for the eighth consecutive quarter.
Broadcom (AVGO) stock fell ~8.5% after markets closed yesterday following the semiconductor giant's fiscal 2019 second-quarter earnings release. It missed analysts' revenue estimate and cut its fiscal 2019 revenue guidance by $2 billion to $22.5 billion due to sluggishness in its semiconductor solutions business.
The SPDR Gold Shares ETF (GLD), which tracks physical gold prices, has underperformed the broader markets year-to-date, rising just 4.4% compared to the S&P 500’s (SPY) gain of 15.9% as of June 14. The sentiment for gold, however, has been turning around.
Safe havens such as Treasuries and gold were back in favor on June 14 as stocks fell due to rising tensions in the Middle East, concerns over growth, and the looming threat of the US-China trade war. The tech-heavy Nasdaq Composite Index fell 0.67% in the first hour of trading.
Lululemon (LULU) stock rose 2.1% on June 13 in reaction to better-than-expected first-quarter results and an upgraded outlook for fiscal 2019 overall. The company's first-quarter adjusted EPS grew 34.5% to $0.74 on revenue growth of 20.4% to $782.32 million. Analysts had expected EPS of $0.70 and revenue of $755.31 million. Here's why the outlook got an upgrade.
As of 4:40 AM Eastern Time today, US crude oil active futures were at $51.83, ~4% below their closing level in the previous week. If US crude oil prices stay at those levels today, they'll mark their third week of decline in five weeks.
Amazon is discontinuing its Amazon Restaurants service, which has been delivering food for restaurants in parts of the United States. Amazon Restaurants launched in the United States in 2015 and entered the British market the following year. However, it met strong opposition in the British market.